Laboratory Methods for Detecting Prenatal Exposure to Cocaine Roger L. Bertholf, Ph.D. Associate Professor of Pathology Chief of Clinical Chemistry & Toxicology.

Slides:



Advertisements
Similar presentations
Forensic Drug Testing Part 1: Screening
Advertisements

Presenters: Promoting Regulatory Excellence Use of Substance Abuse Testing in Licensure Actions Donna R. Smith, PhD FirstLab, Inc.
Fetal alcohol syndrome
The Placenta All The placenta The placental barrier To leave programme.
Drugs and the Fetus Ashley McArdle Tahnee Seibert Holly Horkman.
Prenatal Care ..
Drugs Used During Pregnancy & Lactation
Center for the Health Assessment of Mothers and Children of Salinas chamacos.org present Brenda Eskenazi, Ph.D December 16, 2005.
EOH:2504 Principles of Environmental Exposure Instructor: Dr. Volz Yi-Han Huang EOH MPH student Dec
CHAPTER 3 Life Span Considerations
Lisa Hackenmueller Caitlin McNamara Katrina Awker.
PRENATAL DEVELOPMENT FETAL SUPPORT SYSTEM. OBJECTIVES You will be able to:  Identify and describe the fetal support system  Analyze the interdependence.
The amount of additional iron needed for RBCs expansion depends on the numbers of fetuses. WHO recommends iron supplements 30–60 mg/day if the woman has.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 9 Drug Therapy During Pregnancy and Breast-Feeding.
Practicalities of Conducting Biological Assessments for Drug Use Kenzie L. Preston, Ph.D. Chief, Clinical Pharmacology and Therapeutics Research Branch.
Karl Williams, MD, MPH Medical Examiner Allegheny County.
Use of ACE Inhibitors in Pregnant Women and the Risk of Congenital Heart Defects De-Kun Li, MD, PhD Division of Research Kaiser Permanente Northern California.
Underweight pregnant women in low risk populations: Does a low BMI (
4/20/2017.
Summer 2012 Practicum Veliky Novgorod, Russia Julie Mooza Department of Epidemiology, University of Massachusetts.
Amniotic Fluid Problems. Amniotic fluid is an important part of pregnancy and fetal development. This watery fluid is inside a casing called the amniotic.
DEVELOPMENT AND UTLILITY OF DIRECT ALCOHOL BIOMARKERS
Life Cycle: Maternal and Infant Nutrition BIOL 103, Chapter 12-1.
Lecture Outline Periods of Prenatal Development –Period of the zygote –Period of the embryo –Period of the fetus Teratogens –General Principles –Cigarette.
Lecture Outline Conception Periods of Prenatal Development –Period of the zygote –Period of the embryo –Period of the fetus.
Methamphetamine (MA) use continues to be a significant problem in the United States. The number of adults age 12 and over who have tried MA once in their.
An Ounce of Prevention  2000, 2005, 2011 The Curators of the University of Missouri Preconception Planning and Monitoring Fetal Health Twenty Questions.
Unit 8: Drugs and Nutrition K Eichmann, MS, RD.  Reduced appetite  Taste changes  Decreased motility  Offensive odors  Nausea/vomiting  Increased.
State of the Art Determination of Fetal Drug and Alcohol Exposure Douglas Lewis United States Drug Testing Laboratories.
INFANT BIRTH OUTCOMES AMONG SUBSTANCE USING WOMEN: WHY QUITTING SMOKING IS JUST AS IMPORTANT AS QUITTING HARDER DRUGS Beth Bailey, PhD; Judy McCook, PhD,
Current Trends In Identifying And Treating Newborns With Withdrawal Syndromes 6/24/2010.
The Global Issue of FASD: Results of Characterizing Alcohol Consumption in Pregnancy in Montevideo, Uruguay Janine Hutson, MSc Faculty of Medicine, University.
Pregnancy and Drug Abuse Eva Janecek-Rucker. Learning Objectives 1.To develop a knowledge base of the effects of substances of abuse (e.g., alcohol, cocaine,
DO NOW: Explain in your own words the changes that occur to chromosome number during fertilization.
Fluoxetine transfer into breast milk in sheep Author: Author: Groșan Alexandra Coauthor: Coauthor: Cucean Anda.
Joint Dermatologic and Ophthalmic Drugs & Drug Safety and Risk Management Advisory Committee February 26 & 27, 2004 RISK MANAGEMENT OPTIONS FOR PREGNANCY.
Effect of feeding type on the occurrence of Aflatoxin M1 in cow milk of high producing Dairy cattle in Sri Lanka. G.S.SUMANASEKARA ASCEND RESEARCH NETWORK.
Second Hand Smoke On Infants By Kristy Gutierrez.
Maternal Smoking and Infant Birth Weight Lucinda England, MD, MSPH National Institute of Child Health and Human Development (NICHD)
Section 3- Fetal Alcohol Syndrome There is No Excuse!
Lecture Outline Conception Periods of Prenatal Development –Period of the zygote –Period of the embryo –Period of the fetus.
Period of the Fetus Lasts from the ninth week post-conception until the end of pregnancy (approximately 38 weeks)
CMV In Pregnancy Leili Chamani. MD. MPH. Specialist In Infectious Diseases Department Of Reproductive Health Avesina Research Center (ARC)
1 Stimulating Systems Change for Fetal Alcohol Spectrum Disorder (FASD) Canadian Public Health Association Conference June 2, 2008.
Chapter 4. video XJ5md2iwhttps:// XJ5md2iw.
PRENATAL ENVIRONMENTAL INFLUENCES. Teratogen: any environmental agent that causes damage during prenatal period. Harmful cases lead to babies with major.
New HIV Testing Requirements What Physicians Need to Know.
Health Economics & Policy 3 rd Edition James W. Henderson Chapter 10 Sociocultural Considerations.
WHY should we be concerned about smoking during pregnancy? 27% of women are smokers during their childbearing years. In the National Health Interview Survey.
Principles of Drug Action
1 SAMPLE ALTERNATIVES URINE BLOOD BREATH SALIVA HAIR SWEAT.
HIV and Pregnancy. Introduction In the general obstetrical population in the United States, the frequency of HIV infection is about 1 per The prevalence.
Prenatal Cigarette Smoking and Its Association With Childhood Asthma Jesse Szafarz Pacific University School of Physician Assistant Studies, Hillsboro,
Definition & Risk Factors of FGR FGR, also called IUGR is the term used to describe a fetus that has not reached its growth potential because of genetic.
Amniotic fluid Lec. 18.
Immunosuppressive drugs & treatment of HTN in pregnancy Nephrology dept. R2 우용식.
Katarzyna M. Romek 1,2, Maxime Julien 2, Marine Frasquet-Darrieux 3, Illa Tea 2, Ingrid Antheaume 2, Régis Hankard 3 and Richard J. Robins 2 Protein intake.
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 9 to 11 Drug Therapy Across the Lifespan.
Prenatal Exposure to Phthalates, a Potential Cause of Adverse Fetal Outcomes: A Systematic Review John M. Nightingale Pacific University School of Physician.
Characterization of Phthalate Exposure among Pregnant Women Assessed by Repeat Air and Urine Samples XIAOZHUO LU.
Prenatal Development, Pregnancy, and Birth
Screening and Referral
Neonatal Abstinence Syndrome: An emerging issue for Part C systems?
Prenatal Development. Zygote: conception to 2 weeks
C. Costa, R. Webb, V. Palitsin, M. Ismail, M. de Puit, S. Atkinson, M
Drug Use During Pregnancy:
Ryan Simpson Adrian Smalley Jenessa Dilley
General Principles of Teratogenic Effects:
이 장 우
Presentation transcript:

Laboratory Methods for Detecting Prenatal Exposure to Cocaine Roger L. Bertholf, Ph.D. Associate Professor of Pathology Chief of Clinical Chemistry & Toxicology University of Florida College of Medicine Health Science Center/Jacksonville Roger L. Bertholf, Ph.D. Associate Professor of Pathology Chief of Clinical Chemistry & Toxicology University of Florida College of Medicine Health Science Center/Jacksonville

Why test babies for cocaine? Prevalence of maternal cocaine use Effect of in utero cocaine exposure on fetal and postnatal development Medical/social/legal interventions Prevalence of maternal cocaine use Effect of in utero cocaine exposure on fetal and postnatal development Medical/social/legal interventions

Prevalence of maternal cocaine use 1998 Household Survey revealed that 1.8 million Americans use cocaine (0.8% of population >12 years old) –2% of year-olds; 1.2% of year-olds –0.5% of women are cocaine users Estimates of the prevalence of cocaine use during pregnancy range from less than 2% to more than 15% Reasons for variations –Geographic/socioeconomic/racial –Methods used to detect use 1998 Household Survey revealed that 1.8 million Americans use cocaine (0.8% of population >12 years old) –2% of year-olds; 1.2% of year-olds –0.5% of women are cocaine users Estimates of the prevalence of cocaine use during pregnancy range from less than 2% to more than 15% Reasons for variations –Geographic/socioeconomic/racial –Methods used to detect use

Is prenatal cocaine exposure harmful? Extensive literature on clinical effects of prenatal cocaine exposure Confounding factors are almost always present –Poor prenatal care –Concomitant drug use (alcohol, nicotine) Reliable animal models do not exist –Sheep –Pig –Rodent Extensive literature on clinical effects of prenatal cocaine exposure Confounding factors are almost always present –Poor prenatal care –Concomitant drug use (alcohol, nicotine) Reliable animal models do not exist –Sheep –Pig –Rodent

Well documented physiological effects of cocaine Vasoconstriction –Decreases uterine blood flow in sheep –Cerebral vasodilation and hypertension in newborn sheep and pigs Neurotransmitter deficiencies –ACTH and corticosterone response in rats –Dopamine transporter binding in mice Consistent observations in cocaine exposed neonates –Intrauterine growth retardation (LBW) –Prematurity –Complications/LOS Vasoconstriction –Decreases uterine blood flow in sheep –Cerebral vasodilation and hypertension in newborn sheep and pigs Neurotransmitter deficiencies –ACTH and corticosterone response in rats –Dopamine transporter binding in mice Consistent observations in cocaine exposed neonates –Intrauterine growth retardation (LBW) –Prematurity –Complications/LOS

Does cocaine cross the placenta? Studies in pregnant sheep and rodents indicate that both cocaine and its metabolites cross the placenta –Fetal levels approximately 15% of maternal There is also evidence that the placenta has AChE activity –May have a protective effect Placental transfer of cocaine does not appear to be flow- limited Cocaine can be measured in the amniotic fluid, but there is disagreement over whether it originates solely from fetal urine Studies in pregnant sheep and rodents indicate that both cocaine and its metabolites cross the placenta –Fetal levels approximately 15% of maternal There is also evidence that the placenta has AChE activity –May have a protective effect Placental transfer of cocaine does not appear to be flow- limited Cocaine can be measured in the amniotic fluid, but there is disagreement over whether it originates solely from fetal urine

Other sources of cocaine exposure Breast Milk Passive inhalation Intentional/accidental ingestion Breast Milk Passive inhalation Intentional/accidental ingestion

Detecting prenatal cocaine exposure: Analytical considerations Cocaine metabolism Quantitative thresholds Choice of specimen Cocaine metabolism Quantitative thresholds Choice of specimen

Cocaine metabolism

Cocaethylene

Quantitative thresholds For immunochemical methods, quantitative thresholds are established by calibration –Pure compound or mixture of isomers –Semi-quantitative results for real specimens Purely quantitative results are only available using specific methods –GC/MS –HPLC –GC For immunochemical methods, quantitative thresholds are established by calibration –Pure compound or mixture of isomers –Semi-quantitative results for real specimens Purely quantitative results are only available using specific methods –GC/MS –HPLC –GC

Detecting prenatal cocaine exposure: Methods Immunochemical methods –RIA, ELISA –EMIT –FPIA –CEDIA –POC Spectrometric methods –GC/MS –HPLC –GC Immunochemical methods –RIA, ELISA –EMIT –FPIA –CEDIA –POC Spectrometric methods –GC/MS –HPLC –GC

Immunochemical methods Most are calibrated to a threshold of 300 ng benzoylecgonine per mL of urine –Corresponds to the SAMHSA specifications –May be adapted to other specimens Most are designed to measure benzoylecgonine in urine –Benzoylecgonine is not the principal metabolite in all specimens Most are calibrated to a threshold of 300 ng benzoylecgonine per mL of urine –Corresponds to the SAMHSA specifications –May be adapted to other specimens Most are designed to measure benzoylecgonine in urine –Benzoylecgonine is not the principal metabolite in all specimens

Chromatographic methods Quantitative GC/MS analysis (by isotope dilution) is considered the reference method –Sensitivity <10 ng/mL –Requires extensive specimen preparation (extraction, derivatization, isotopically-labeled internal standards) HPLC has similar sensitivity to GC/MS applications, but detection is less specific –Does not require preparation of volatile derivatives GC is robust and sensitive, but lacks detector specificity –Nitrogen/Phosphorus detectors are very sensitive but expensive Quantitative GC/MS analysis (by isotope dilution) is considered the reference method –Sensitivity <10 ng/mL –Requires extensive specimen preparation (extraction, derivatization, isotopically-labeled internal standards) HPLC has similar sensitivity to GC/MS applications, but detection is less specific –Does not require preparation of volatile derivatives GC is robust and sensitive, but lacks detector specificity –Nitrogen/Phosphorus detectors are very sensitive but expensive

Detecting prenatal cocaine exposure: Specimens Maternal specimens –Urine –Amniotic fluid –Hair Neonatal specimens –Urine –Meconium –Hair –Nails Maternal specimens –Urine –Amniotic fluid –Hair Neonatal specimens –Urine –Meconium –Hair –Nails

Cocaine in maternal specimens Maternal urine is easy to collect, and measurements are reliable –Usually reflects exposure within the past 2-3 days Uncontaminated amniotic fluid is harder to obtain –More direct measure of fetal exposure (may be substitute for screening fetal urine) –Pharmacokinetics of cocaine and metabolites in amniotic fluid have not been established. Hair is the most difficult specimen to analyze, but shows promise as a clinical specimen –Incorporation of cocaine in hair has been widely documented Maternal urine is easy to collect, and measurements are reliable –Usually reflects exposure within the past 2-3 days Uncontaminated amniotic fluid is harder to obtain –More direct measure of fetal exposure (may be substitute for screening fetal urine) –Pharmacokinetics of cocaine and metabolites in amniotic fluid have not been established. Hair is the most difficult specimen to analyze, but shows promise as a clinical specimen –Incorporation of cocaine in hair has been widely documented

Cocaine in neonatal specimens Urine –Sometimes difficult to collect –Can be extracted from diapers Meconium –More difficult to collect uncontaminated specimens –Can also be extracted from diapers Hair –Shows promise, but methods are not widely available Nails –Most data on postmortem specimens Urine –Sometimes difficult to collect –Can be extracted from diapers Meconium –More difficult to collect uncontaminated specimens –Can also be extracted from diapers Hair –Shows promise, but methods are not widely available Nails –Most data on postmortem specimens

Urine drug testing in neonates Typically uses immunoassays configured for workplace drug testing –Positive threshold >300 ng/mL (benzoylecgonine) Most studies indicate that neonatal urine drug screening at conventional thresholds fails to detect up to half of cocaine-exposed infants Results of neonatal urine cocaine screening usually correlate with maternal urine Typically uses immunoassays configured for workplace drug testing –Positive threshold >300 ng/mL (benzoylecgonine) Most studies indicate that neonatal urine drug screening at conventional thresholds fails to detect up to half of cocaine-exposed infants Results of neonatal urine cocaine screening usually correlate with maternal urine

Use of lower screening thresholds

Urine collection from diapers Several studies have documented the correlation between chemistry and microscopic laboratory results on bag-collected and diaper-extracted urine Cocaine, benzoylecgonine, and ecgonine methyl ester can be extracted from diapers with methanol. Several studies have documented the correlation between chemistry and microscopic laboratory results on bag-collected and diaper-extracted urine Cocaine, benzoylecgonine, and ecgonine methyl ester can be extracted from diapers with methanol.

Meconium drug testing The fetus swallows drug-laced amniotic fluid Drugs are deposited in the intestinal contents (or biliary excretion) Meconium, passed in the first bowel movement, contains drugs that have accumulated during the 2 nd and 3 rd trimesters

Is meconium testing better than urine? Several studies comparing urine and meconium results concluded that meconium testing was more sensitive –Analytical bias (RIA vs. EIA) –Cannot exclude the possibility of contamination Studies using urine and meconium methods with comparable sensitivities have reported equivocal results Several studies comparing urine and meconium results concluded that meconium testing was more sensitive –Analytical bias (RIA vs. EIA) –Cannot exclude the possibility of contamination Studies using urine and meconium methods with comparable sensitivities have reported equivocal results

Hair testing Animal studies have demonstrated a dose-related cocaine and benzoylecgonine accumulation in hair Cocaine and benzoylecgonine have been detected in hair specimens collected from cocaine abusing mothers and their infants Potentially the most sensitive method Animal studies have demonstrated a dose-related cocaine and benzoylecgonine accumulation in hair Cocaine and benzoylecgonine have been detected in hair specimens collected from cocaine abusing mothers and their infants Potentially the most sensitive method

Other specimens Blood Amniotic fluid Breast milk Saliva Nails Blood Amniotic fluid Breast milk Saliva Nails

Distribution of cocaine metabolites

Which specimens are most stable?

Comparison of sensitivities

Conclusions Testing for prenatal cocaine exposure is widespread, but clinical indications are not well established None of the methods currently available are capable of measuring the magnitude or duration of prenatal cocaine exposure Urine screens must have greater analytical sensitivity to be useful for detecting prenatal cocaine exposure Neonatal hair testing appears to offer the best clinical sensitivity Testing for prenatal cocaine exposure is widespread, but clinical indications are not well established None of the methods currently available are capable of measuring the magnitude or duration of prenatal cocaine exposure Urine screens must have greater analytical sensitivity to be useful for detecting prenatal cocaine exposure Neonatal hair testing appears to offer the best clinical sensitivity